medigraphic.com
Boletín Clínico de la Asociación Médica del Hospital Infantil del Estado de Sonora

2011, Number 2

<< Back Next >>

Bol Clin Hosp Infant Edo Son 2011; 28 (2)

Kawasaki Disease, Presentation of a Case and Review of the Literature

Zárate-Aspiros R, Cruz-Ortiz JR, Rosas-Sumano AB, Ciprian V

Language: Spanish
References: 26
Page: 61-65
PDF size: 102.39 Kb.


ABSTRACT

Introduction: Kawasaki disease is an acute febrile syndrome characterized by systemic vasculitis of unknown etiology that occurs mainly in children under five years old. The diagnosis is clinical, but sometimes the presentation is atypical, making diagnosis difficult.
A case in point is of a patient 1 year 10 months of age with a fever of 10 days duration, treated at the Hospital General de Oaxaca “Dr. Aurelio Valdivieso”, in whom Kawasaki disease was suspected. The patient was evaluated by pediatric cardiology by echocardiogram, which was reported initially normal. He was treated with intravenous gamma globulin and acetylsalicylic acid; nonetheless, coronary artery dilation was detected during a follow-up study.
We believe that there is a under-diagnosis of Kawasaki disease in our community. Given the importance of early diagnosis and prompt treatment in a patient with suggestive data, and taking into account that the signs are not entirely typical in 100% of cases, (as in our aforementioned patient) cardiac evaluation and the initiation of treatment are essential, even when the diagnosis is made after the tenth day of illness.


REFERENCES

  1. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement or Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Pediatrics 2004, 114: 1708-33.

  2. American Academia of Pediatrics. Enfermedaad de Kawasaki. En Manual de referencia para la emergencia y la urgencia pediátrica. Academia Americana de Pediatria, Colegio Americano de Emergencias Médicas. Primera edición en español 2007. Editorial Medica A.W.W.E. pag 123-5.

  3. Freeman AF, Shulman ST Kawasaki Disease: Summary of the American Heart Association Guidelines. Am Fam Physician. 2006;74(7) : 1141-48.

  4. Kim D. Kawasaki Disease. Yonsei Med J 2006;47(6): 759-72.

  5. Fimbres AM, Stanford T, Shulman S Enfermedad de Kawasaki. Pediatrics rev 2008; 29: 308-16.

  6. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [in Japanese]. Arerugi 1967; 16: 178-222.

  7. Yamamoto T, Oya T, Watanabe A, et al. Clinical features of Kawasaki disease [in Japanese]. Shonika Rinsho (Jpn J Pediatr) 1968; 21: 291-7.

  8. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54: 271-6.

  9. Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants less than one year of age. J Pediatr 1995; 126: 524-9.

  10. Coronel-Rodríguez W, Tello GI, Erdmenger- Orellana J, Coria-Lorenzo JJ. Gómez-Barreto D, Síndrome de Kawasaki. Paciente de menor edad reportado en la casuística del Hospital Infantil de México «Federico Gómez». Bol Med Hosp Infant Mex 2002; 59(7): 430-6.

  11. 11.Stockheim JA, Innocentini N, Shulman ST. Kawasaki disease in older children and adolescents. J Pediatr 2000; 137: 250-2.

  12. Rodríguez-Suárez R. Síndrome linfomucocutáneo. Presentación de un caso. Bol Med Hosp Infant Mex 1977; 34: 53-7.

  13. Vizcaíno-Alarcón A, Arévalo-Salas A, Rodríguez-López AM, Sadowinsky-Pine S. Enfermedad de Kawasaki en niños mexicanos. Bol Med Hosp Infant Mex 1991; 48(6): 398-408.

  14. González-Galnares M, Urbán-Vázquez H, Santamaría-Díaz H, Gorbea-Robles MC. Enfermedad de Kawasaki en México: análisis de 13 casos. Bol Med Hosp Infant Mex 1991; 48(6): 409-16.

  15. Coria Lorenzo JJ, Cervantes Parra V, Uritz Jerónimo F, Reyes Lopez A, Coria Guerrero JA, Caracteristicas clínicas de niños con Kawasaki atípico en un hospital de alta especialización. RevMex Ped 2007; 74(1): 9-15.

  16. Quezada-Chavarría G, Ramírez-Serrallonga R, Quezada-Cuevas SE, Salazar-Salas J, Fernández-Gómez I, Esparza-Pérez RI. Enfermedad de Kawasaki, Análisis de 17 casos. Rev Med Inst Mex Seguro Soc 2009; 47 (1): 61-4.

  17. Sotelo-Cruz N, González-Ramos LA, Gómez-Rivera N, Manzo-Ríos MA. Enfermedad de Kawasaki. Experiencia en siete niños Rev Mex Pediatr 2001; 68(5):189-95.

  18. Sotelo N, Gonzalez LA. Kawasaki disease: A rare pediatric pathology in Mexico Twenty cases report from the Hospital Infantil del Estado de Sonora. Arch Cardiol Mex 2007; 77(4): 299-307.

  19. Del Angel-Aguilar A, Rodríguez-Herrera R, Díaz-Luna JL, et al. Enfermedad de Kawasaki Experiencia en un hospital de segundo nivel. Revista de enfermedades Infecciosas en Pediatría 2009; 22 (87): 70-6.

  20. Kim HY, Lee HG, Kim DS. Apoptosis of peripheral blood mononuclear cells in Kawasaki disease. J Rheumatol 2000; 27: 801-6.

  21. Leung DY, Giorno RC, Kazemi LV, Flynn PA, Busse JB. Evidence for superantigen involvement in ca rdiovascular injury due to Kawasaki syndrome. J Immunol 1995; 155: 5018-21.

  22. Rowley AH, Shulman ST, Spike BT, Mask CA, Baker SC. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol 2001; 166: 1334-43.

  23. Brown TJ, Crawford SE, Cornwall ML, Garcia F, Shulman ST, Rowley AH. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis 2001; 184: 940-3.

  24. Matsubara T, Ichiyama T, Furukawa S. Inmunological profile of peripheral blood lymphocytes and monocytes/marcrophages in Kawasali disease Clin Exp Inmunol 2005; 141(3): 381-7.

  25. Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 2003;(4): CD004000.

  26. Muta H, Ishii M, Egami K, Furui J, Sugahara Y, Akagi T, et al. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan. J Pediatr 2004; 144: 496-9.




2020     |     www.medigraphic.com